Valuation: AFT Pharmaceuticals Limited

Market Cap 412M 241M 211M 195M 179M 339M 23.23B 344M 2.33B 915M 11.37B 905M 885M 39.16B P/E 2027 *
20.9x
P/E 2028 * 16.6x
Enterprise Value 442M 258M 226M 209M 192M 363M 24.91B 369M 2.5B 981M 12.19B 970M 949M 41.99B EV / Sales 2027 *
1.45x
EV / Sales 2028 * 1.26x
Free-Float
22.37%
Yield 2027 *
0.83%
Yield 2028 * 1.06%
1 day+0.51%
1 week+0.51%
Current month+7.38%
1 month+7.67%
3 months+9.47%
6 months+3.69%
Current year+16.27%
1 week 3.91
Extreme 3.91
4
1 month 3.66
Extreme 3.66
4
Current year 3.35
Extreme 3.35
4
1 year 2.54
Extreme 2.54
4
3 years 2.37
Extreme 2.37
4
5 years 2.37
Extreme 2.37
5
10 years 1.7
Extreme 1.7
5.65
Manager TitleAgeSince
Human Resources Officer - 03/09/2012
Chief Executive Officer - 03/09/1997
Director of Finance/CFO - 14/06/2026
Director TitleAgeSince
Chairman - 21/06/2015
Director/Board Member - 03/09/1997
Director/Board Member - 03/09/2012
Date Insider Type Main position Quantity % Market Cap.
03/07/25 Buy

Founder

200,000 0.1907%
26/06/25 Free

Founder

17,755 0.0169%
02/12/24 Buy

Founder

45 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.51%+0.51%+45.56%+5.36% 240M
-2.73%-1.59%+52.60%+150.76% 1,051B
-1.67%-3.05%+52.04%+48.41% 609B
-0.44%+2.11%+36.99%+78.09% 450B
-0.75%-1.46%+28.32%+22.33% 330B
-1.52%-0.95%+33.38%+38.39% 284B
-1.70%-3.54%+20.26%+17.88% 263B
-0.58%+1.78%-20.89%-38.37% 223B
-0.58%+1.34%+23.46%+56.62% 198B
-0.80%+1.69%+23.40%+67.14% 167B
Average -0.83%+0.55%+29.51%+44.66% 357.53B
Weighted average by Cap. -1.15%-0.22%+36.83%+72.70%

Financials

2027 *2028 *
Net sales 304M 178M 156M 144M 132M 250M 17.13B 254M 1.72B 674M 8.38B 667M 652M 28.87B 345M 202M 177M 164M 150M 284M 19.46B 288M 1.96B 766M 9.52B 758M 741M 32.81B
Net income 19.71M 11.52M 10.1M 9.33M 8.58M 16.2M 1.11B 16.46M 112M 43.75M 544M 43.26M 42.31M 1.87B 24.84M 14.52M 12.72M 11.76M 10.82M 20.41M 1.4B 20.74M 141M 55.13M 685M 54.51M 53.32M 2.36B
Net Debt 29.84M 17.44M 15.29M 14.13M 12.99M 24.52M 1.68B 24.91M 169M 66.23M 823M 65.49M 64.06M 2.83B 24.59M 14.37M 12.6M 11.64M 10.71M 20.2M 1.39B 20.53M 139M 54.57M 678M 53.96M 52.79M 2.34B
Logo AFT Pharmaceuticals Limited
AFT Pharmaceuticals Limited is a New Zealand-based multinational pharmaceutical company. The Company develops, markets, and distributes a portfolio of pharmaceutical products across a range of therapeutic categories, which are distributed across three pharmaceutical distribution channels: over the counter (OTC), prescription and hospital. Its product portfolio comprises both proprietary and in-licensed products, and includes patented, branded, and generic drugs. The Company develops and in-licenses products for sale by sales teams in Australia and New Zealand and in certain Southeast Asian markets, and out-licenses its products to local licensees and distributors in the rest of the world. Its products include A-Scabies, Allersoothe, Allersoothe Elixir, BecloClear, Candaderm, Coco-Scalp, Cromo-Fresh, Fenpaed, Fenpaed Double Strength, Ferro-Sachets, HYLO-FORTE, Itch-Soothe, Kiwisoothe, Lax-Tab, Loraclear, VitA-POS, and others.
Employees
126
Date Price Change Volume
19/07/26 NZ$3.930 +0.51% 3,630
17/07/26 NZ$3.910 -1.51% 8,861
16/07/26 NZ$3.970 +1.53% 3,029
15/07/26 NZ$3.910 -0.26% 18,750
14/07/26 NZ$3.920 -0.51% 42,056
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.930NZD
Average target price
4.650NZD
Spread / Average Target
+18.32%

Annual profits - Rate of surprise